|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.68 EUR | -0.08% |
|
-6.22% | -11.48% |
| Mar. 30 | Ionos share buyback program will be carried out from 30 March | RE |
| Mar. 26 | Berenberg Stays Constructive on Ionos Amid Positive Customer Momentum | MT |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | 9.18 | 8.58 | 11.08 | 12.42 | 13.58 | |||
Return on Total Capital | 13.89 | 10.82 | 14.01 | 16.01 | 17.84 | |||
Return On Equity % | -22.2 | -37.76 | -211.26 | 217.56 | 88.41 | |||
Return on Common Equity | -21.64 | -37.2 | -210.91 | 217.94 | 88.46 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | 51.47 | 46 | 48.17 | 48.65 | 59.41 | |||
SG&A Margin | 31.01 | 29.68 | 29.2 | 27.27 | 32.53 | |||
EBITDA Margin % | 28.12 | 22.86 | 25.51 | 26.33 | 33.15 | |||
EBITA Margin % | 21.86 | 17.62 | 20.8 | 21.82 | 27.93 | |||
EBIT Margin % | 19.71 | 15.99 | 19.53 | 20.63 | 26.51 | |||
Income From Continuing Operations Margin % | 5.61 | 5.75 | 12.24 | 10.87 | 15.37 | |||
Net Income Margin % | 5.52 | 5.71 | 12.24 | 10.87 | 17.44 | |||
Net Avail. For Common Margin % | 5.52 | 5.71 | 12.24 | 10.87 | 15.37 | |||
Normalized Net Income Margin | 5.44 | 5.28 | 9.79 | 10.37 | 14.58 | |||
Levered Free Cash Flow Margin | 15.68 | 5.28 | 6.29 | 15.88 | 18.23 | |||
Unlevered Free Cash Flow Margin | 21.09 | 9.84 | 10.01 | 16.85 | 18.78 | |||
Asset Turnover | ||||||||
Asset Turnover | 0.75 | 0.86 | 0.91 | 0.96 | 0.82 | |||
Fixed Assets Turnover | 4.74 | 4.52 | 4.48 | 4.98 | 4.39 | |||
Receivables Turnover (Average Receivables) | 20.16 | 18.46 | 17.33 | 16.44 | 15.31 | |||
Inventory Turnover (Average Inventory) | 39.66K | 7.93K | 6.39K | 13.03K | 14.45K | |||
Short Term Liquidity | ||||||||
Current Ratio | 0.58 | 0.59 | 0.75 | 0.75 | 0.22 | |||
Quick Ratio | 0.48 | 0.48 | 0.64 | 0.65 | 0.17 | |||
Operating Cash Flow to Current Liabilities | 0.72 | 0.63 | 1.05 | 1.07 | 0.35 | |||
Days Sales Outstanding (Average Receivables) | 18.11 | 19.77 | 21.06 | 22.26 | 23.84 | |||
Days Outstanding Inventory (Average Inventory) | 0.01 | 0.05 | 0.06 | 0.03 | 0.03 | |||
Average Days Payable Outstanding | 39.41 | 40.83 | 45.12 | 48.9 | 67.49 | |||
Cash Conversion Cycle (Average Days) | -21.29 | -21.01 | -24 | -26.62 | -43.62 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | -607.46 | -847.25 | -45.75K | 683.57 | 302.12 | |||
Total Debt / Total Capital | 119.71 | 113.38 | 100.22 | 87.24 | 75.13 | |||
LT Debt/Equity | -603.04 | -838.75 | -45.19K | 674.52 | 30.31 | |||
Long-Term Debt / Total Capital | 118.84 | 112.24 | 99 | 86.08 | 7.54 | |||
Total Liabilities / Total Assets | 115.74 | 110.52 | 100.17 | 90.34 | 80.96 | |||
EBIT / Interest Expense | 2.28 | 2.19 | 3.28 | 13.41 | 29.84 | |||
EBITDA / Interest Expense | 3.39 | 3.3 | 4.48 | 17.77 | 38.66 | |||
(EBITDA - Capex) / Interest Expense | 2.42 | 2.27 | 3.51 | 14.57 | 33.14 | |||
Total Debt / EBITDA | 4.35 | 4.42 | 3.36 | 2.54 | 2 | |||
Net Debt / EBITDA | 4.19 | 4.33 | 3.28 | 2.47 | 1.94 | |||
Total Debt / (EBITDA - Capex) | 6.1 | 6.42 | 4.28 | 3.1 | 2.33 | |||
Net Debt / (EBITDA - Capex) | 5.87 | 6.29 | 4.18 | 3.01 | 2.26 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | 11.64 | 17.19 | 10.11 | 9.59 | 5.51 | |||
Gross Profit, 1 Yr. Growth % | 5.63 | 4.72 | 15.32 | 10.68 | 10.41 | |||
EBITDA, 1 Yr. Growth % | -2.27 | -2.83 | 22.86 | 13.12 | 17.71 | |||
EBITA, 1 Yr. Growth % | -4.28 | -5.93 | 30.05 | 14.93 | 22.41 | |||
EBIT, 1 Yr. Growth % | -3.42 | -4.92 | 34.5 | 15.8 | 23.8 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | -18.49 | 20.07 | 134.29 | -2.63 | 56.19 | |||
Net Income, 1 Yr. Growth % | -19.32 | 21.09 | 136.17 | -2.62 | 35.38 | |||
Normalized Net Income, 1 Yr. Growth % | -17.93 | 13.66 | 85.7 | 16.11 | 40.96 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | - | 21.09 | -99.4 | -3.25 | 58.24 | |||
Accounts Receivable, 1 Yr. Growth % | 25.71 | 29.79 | 7.69 | 22.73 | -35.5 | |||
Inventory, 1 Yr. Growth % | 7.69 | 1.06K | -57.41 | -21.74 | -62.96 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | 18.57 | 26.5 | -0.87 | -2.09 | -6.54 | |||
Total Assets, 1 Yr. Growth % | -1.13 | 4.75 | 3.55 | 2.96 | -4.47 | |||
Tangible Book Value, 1 Yr. Growth % | -7.12 | -7.99 | -14.67 | -17.74 | -21.26 | |||
Common Equity, 1 Yr. Growth % | -28.71 | -30.73 | -98.2 | -5.53K | 88.42 | |||
Cash From Operations, 1 Yr. Growth % | 20.36 | -6.09 | 14.17 | 22.99 | 1.31 | |||
Capital Expenditures, 1 Yr. Growth % | 39.27 | 4.35 | -15.83 | -5.91 | -16.05 | |||
Levered Free Cash Flow, 1 Yr. Growth % | 7.93 | -60.53 | 31.22 | 140.12 | 8.16 | |||
Unlevered Free Cash Flow, 1 Yr. Growth % | 3.02 | -45.31 | 11.98 | 68.36 | 4.42 | |||
Compound Annual Growth Rate Over Two Years | ||||||||
Total Revenues, 2 Yr. CAGR % | 9.27 | 14.38 | 13.6 | 9.85 | -3.83 | |||
Gross Profit, 2 Yr. CAGR % | 5.86 | 5.18 | 9.89 | 12.98 | 6.81 | |||
EBITDA, 2 Yr. CAGR % | 5.77 | -3.5 | 9.27 | 17.89 | 9.63 | |||
EBITA, 2 Yr. CAGR % | 3.74 | -4.93 | 10.6 | 22.25 | 11.43 | |||
EBIT, 2 Yr. CAGR % | 5.68 | -4.17 | 13.08 | 24.8 | 12.06 | |||
Earnings From Cont. Operations, 2 Yr. CAGR % | 6.85 | -1.07 | 67.73 | 51.04 | 7.76 | |||
Net Income, 2 Yr. CAGR % | 6.26 | -1.16 | 69.11 | 51.65 | 14.82 | |||
Normalized Net Income, 2 Yr. CAGR % | 8.27 | -3.42 | 52.37 | 46.84 | 17.39 | |||
Diluted EPS Before Extra, 2 Yr. CAGR % | - | -1.16 | -91.47 | -92.38 | 8.2 | |||
Accounts Receivable, 2 Yr. CAGR % | -23.58 | 27.73 | 18.22 | 14.96 | -11.03 | |||
Inventory, 2 Yr. CAGR % | -36.75 | 253.01 | 122 | -42.26 | -46.16 | |||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.02 | 22.48 | 11.98 | -1.48 | -4.34 | |||
Total Assets, 2 Yr. CAGR % | -0.95 | 1.76 | 4.15 | 3.26 | -0.82 | |||
Tangible Book Value, 2 Yr. CAGR % | -8.51 | -7.56 | -11.39 | -16.21 | -19.52 | |||
Common Equity, 2 Yr. CAGR % | -26.41 | -29.73 | -88.84 | -1.14 | 911.86 | |||
Cash From Operations, 2 Yr. CAGR % | 9.58 | 6.32 | 25.23 | 18.5 | 11.62 | |||
Capital Expenditures, 2 Yr. CAGR % | 11.7 | 20.55 | -6.28 | -11.01 | -11.12 | |||
Levered Free Cash Flow, 2 Yr. CAGR % | 154.55 | -34.73 | -28.03 | 90.53 | 52.5 | |||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 55.43 | -24.94 | -21.75 | 43.72 | 25.87 | |||
Compound Annual Growth Rate Over Three Years | ||||||||
Total Revenues, 3 Yr. CAGR % | 7.96 | 11.85 | 12.94 | 12.25 | 0.61 | |||
Gross Profit, 3 Yr. CAGR % | 6.36 | 5.48 | 8.45 | 10.16 | 9.57 | |||
EBITDA, 3 Yr. CAGR % | 6.4 | 2.15 | 4.59 | 10.53 | 13.88 | |||
EBITA, 3 Yr. CAGR % | 4.55 | 0.53 | 5.53 | 12.03 | 17.32 | |||
EBIT, 3 Yr. CAGR % | 5.98 | 2.02 | 7.29 | 13.98 | 19.09 | |||
Earnings From Cont. Operations, 3 Yr. CAGR % | 9.19 | 11.09 | 31.87 | 39.92 | 39.61 | |||
Net Income, 3 Yr. CAGR % | 8.9 | 10.99 | 32.14 | 40.69 | 46.02 | |||
Normalized Net Income, 3 Yr. CAGR % | 0.54 | 10.04 | 23.97 | 39.17 | 36.78 | |||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | 10.99 | -81.97 | -80.84 | -80.85 | |||
Accounts Receivable, 3 Yr. CAGR % | -9.46 | -8.82 | 20.67 | 19.71 | -5.18 | |||
Inventory, 3 Yr. CAGR % | -39.11 | 66.65 | 74.44 | 56.83 | -50.21 | |||
Net Property, Plant and Equip., 3 Yr. CAGR % | 18.39 | 19.42 | 14.14 | 7.08 | -3.2 | |||
Total Assets, 3 Yr. CAGR % | -1.05 | 0.92 | 2.36 | 3.75 | 0.62 | |||
Tangible Book Value, 3 Yr. CAGR % | -7.55 | -8.34 | -9.99 | -13.56 | -17.93 | |||
Common Equity, 3 Yr. CAGR % | -22.52 | -27.88 | -79.29 | -12.19 | 22.57 | |||
Cash From Operations, 3 Yr. CAGR % | 24.17 | 4.08 | 23.58 | 24.48 | 12.47 | |||
Capital Expenditures, 3 Yr. CAGR % | 6.53 | 9.19 | 6.95 | -6.16 | -12.72 | |||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 36.75 | -17.62 | 12.74 | 52.06 | |||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 9.73 | -14.23 | 4.15 | 24.8 | |||
Compound Annual Growth Rate Over Five Years | ||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 10.18 | 11.05 | 5.91 | |||
Gross Profit, 5 Yr. CAGR % | - | - | 7.76 | 8.42 | 7.79 | |||
EBITDA, 5 Yr. CAGR % | - | - | 7.12 | 8.18 | 6.58 | |||
EBITA, 5 Yr. CAGR % | - | - | 7.01 | 8.71 | 7.85 | |||
EBIT, 5 Yr. CAGR % | - | - | 8.76 | 10.59 | 9.17 | |||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 29.64 | 25.62 | 21.64 | |||
Net Income, 5 Yr. CAGR % | - | - | 29.86 | 25.75 | 24.92 | |||
Normalized Net Income, 5 Yr. CAGR % | - | - | 18.73 | 25.87 | 21.29 | |||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | -61.98 | -63.07 | |||
Accounts Receivable, 5 Yr. CAGR % | - | - | 0.74 | 0.04 | 6.82 | |||
Inventory, 5 Yr. CAGR % | - | - | 2.16 | 9.06 | 9 | |||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 15.79 | 10.57 | 6.35 | |||
Total Assets, 5 Yr. CAGR % | - | - | 1 | 1.85 | 1.07 | |||
Tangible Book Value, 5 Yr. CAGR % | - | - | -9.11 | -11.58 | -13.93 | |||
Common Equity, 5 Yr. CAGR % | - | - | -64.31 | -18.18 | -1.88 | |||
Cash From Operations, 5 Yr. CAGR % | - | - | 24.59 | 18.29 | 18.65 | |||
Capital Expenditures, 5 Yr. CAGR % | - | - | 1.21 | 0.61 | -0.68 | |||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 56.15 | 8.41 | |||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 22.23 | 1.83 |
- Stock Market
- Equities
- IOS Stock
- Financials IONOS Group SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















